Abstract -A better understanding of cell-mediated immune responses to classical swine fever virus (CSFV) is essential for the future development of improved vaccines. We analyzed the generation of cell-mediated and humoral immune responses in d/d histocompatible pigs following CSFV infection or vaccination. Viral infection induced high T cell responses with high primary and secondary CTL activity correlated with high IFN-g production, whereas vaccination with a live vaccine followed by infection mainly induced neutralizing antibody but low cell-mediated responses. Moreover, high IgG1 response was associated with high IFN-g response following infection whereas a weak IFN-g response was related to a good IgG2 response but a low IgG1 production. These data could reflect Th1/Th2-like balance of immune responses depending upon immunization protocols, which has not yet been described in the pig. T-cell responses to CSFV were evidenced by CSFV-specific CD25 upregulation on CD4 -CD8 + , but not on CD4 + CD8 -cells, which further illustrated the importance of CTL responses after infection. Our results indicated that generation of cell-mediated immune responses was much higher following intranasal/oral CSFV infection than after intramuscular vaccination, which implies that the capacity of new CSFV vaccines to induce higher T-cell responses should be considered.
INTRODUCTION
Classical swine fever virus (CSFV) is a small enveloped RNA virus which belongs to the genus Pestivirus of the family Flaviviridae [33] . This virus causes acute, subacute or chronic disease in swine, which always leads to severe economic losses in the pig industry. In the past, vaccination against CSF using inactivated or attenuated live virus vaccines was used to control CSF outbreaks or chronic infection in 390 L. Piriou et al. domestic pig populations. Because these vaccines did not permit discrimination between vaccinated pigs and infected animals, the European Union moved its eradication program to a non vaccination and stamping out policy in 1990. However, due to changes in the biology of this virus and pig trading schemes, it has become more difficult to limit the impact of CSF outbreaks in some areas with high pig density, without using vaccination. It is therefore essential to develop subunit or "marker" vector vaccines to allow the vaccination of pigs in such outbreaks, limiting at the same time the restrictions on the trade of living pigs and pig meat products.
The understanding of cellular immune responses against viral infection is of major importance for the design of new and potent vaccines. So far, most studies have only concerned the humoral immune response of CSFV-infected animals. In infected pigs, a clear relationship between the presence of serum antibodies that neutralize the virus in vitro and protection against CSFV has been established in many studies suggesting that these neutralizing antibodies alone can control the replication of the virus in vivo [29] . However, in some instances where neutralizing antibodies were not detectable, a relative protection was observed suggesting a possible protective role for T cells [21] . Cellular immune responses, especially virus-specific cytotoxic T lymphocytes (CTL), have been shown to represent an important defense mechanism against African Swine Fever Virus (ASFV) infection in pigs [13] . These mechanisms have also been demonstrated for the Pestiviruses bovine viral diarrhea virus [3] and border disease virus [34] . Pauly et al. [15] demonstrated the existence of CSF-CTLs in peripheral blood mononuclear cells (PBMC) from immunized pigs. However, nothing has been reported so far about the kinetics and the magnitude of CTL activity after natural infection or vaccination. On the contrary, although CSFV-specific lymphoproliferative responses were demonstrated in CSFVimmune animals [9] , other authors reported a decrease of PBMC proliferative responses in CSFV infected pigs [5, 24, 32] . In fact, this inhibitory effect observed in vitro may largely be due to the tropism of the virus for the immune system, in particular for PBMC [28] , and the virus capacity to induce both severe lymphopenia and immunosuppression.
The objective of this study was to analyze in detail the kinetics of T-cell responses, including CTL and cytokine production, against CSFV in histocompatible d/d pigs. CSFV infection induced stronger T-cell responses than vaccination with a live virus followed by challenge infection, which suggests that further efforts should be made to improve the capacity of CSFV vaccines to induce higher T-cell responses.
MATERIALS AND METHODS

Viruses and titration
CSFV Thiverval attenuated strain (Coglapest ® vaccine, titer: 10 3.8 TCID 50 ) was kindly supplied by CEVA-Phylaxia, Budapest, Hungary. CSFV virulent Alfort strain (titer: 10 5 TCID 50 ) was obtained from Hannover (Germany) and was propagated in the pig kidney cell line PK-15.
Animals and experimental protocols
Animals
Pigs of the d/d haplotype were kindly supplied by H. Salmon and P. Lechopier (INRA, Nouzilly, France).
CSFV immunization protocols
Two pigs of the d/d haplotype, hereafter referred to as the challenged ("chall") pigs, were infected by the intranasal route with a subacute dose of the CSFV Alfort strain (10 4.5 TCID 50 ), to "mimic" a natural route of Immune responses of pigs after CSF infection 391 infection. Two other d/d pigs were intramuscularly immunized (vaccination) with the Thiverval attenuated strain (coglapest ® vaccine, 10 3.8 PFU) followed by one intramuscular inoculation (challenge) of 10 4.5 TCID 50 of the CSFV Alfort strain at week 3. These two pigs served to induce strong and possibly both cell and antibodymediated immune responses to CSFV. They will be referred to as vaccinated and challenged ("vacc/chall") pigs. Two control pigs were not immunized and not inoculated. Clinical observations, body weight and temperature were monitored daily from days 0 to 74 post-vaccination and infection (PI). Blood was collected weekly for preparation of PBMC and serum. The investigation of humoral and cellular immunity was achieved in all pigs with the methods described below. Presence of viral RNA was assayed by RT-PCR as described below. Clinical signs after challenge were monitored.
Laboratory investigations
CSFV antibody titration
Serum samples were tested for the presence of neutralizing antibodies against CSFV using a neutralizing immunofluorescence test already described [11, 20] .
Titration of anti-CSFV IgA, IgG, IgG1 and IgG2: Anti-CSFV serum antibodies (Ab) were detected by indirect ELISA, using microplates coated with whole CSFV antigens (Platelia hog cholera, Biorad, France). The plates were first washed in PBS-0.05% Tween 80 -1% dried skimmed milk. Then test-sera diluted to 1/100 in PBS-0.05% Tween 80 were added and incubated for 1 h at 37°C. After washing, the wells were filled for 1 h at 37°C with either 100 mL of 1/1000 anti-IgG1 mAb or 100 mL of 1/45000 anti-IgG2 mAb or 100 mL of 1/2000 anti-IgG mAb or 100 mL of 1/2000 anti-IgA mAb (all mAb from Iddlo, Lelystad, The Netherlands). Then, 100 mL of 1/1000 rabbit peroxidase-labeled anti-mouse IgG (Jackson immunoresearch, Pennsylvania, USA) were added for 1 h at 37°C. Optical densities (OD) were read at 450 nm after tetramethylbenzidine staining.
Detection of CSFV mRNA
CSFV in blood and serum was detected by nested RT-PCR as previously described by Mc Goldrick et al. [14] .
Preparation of peripheral blood mononuclear cells
PBMC were isolated from heparinized blood by centrifugation on ficoll-hypaque (Pharmacia, Uppsala, Sweden). These cells were resuspended in complete medium until use or frozen in fetal bovine serum (FBS, Dutscher, F) -10% DMSO for later use. Complete medium was constituted of RPMI 1640 (Gibco-BRL,UK) supplemented with 10% FBS, 1 mM sodium pyruvate (Sigma, St Louis, MO, USA), 100 UI/ mL penicillin (Sigma), 0.1 mg/mL streptomycin (Sigma) and 1% glucose (Sigma).
CSFV-specific cell proliferative response
The proliferative response of PBMC after CSFV in vitro re-stimulation was measured by bromodeoxyuridine incorporation [1, 16] . We adapted this method for use in flow cytometry and double or triple labeling in order to evaluate the specific proliferation of B and T cell sub-populations. PBMC (3´10 5 cells) were incubated with 100 mL of infectious virus (3´10 7 TCID 50 /mL of cells) for 4 days at 37°C with 200 mM BRDU. The negative controls (medium) and positive controls (phytohaemagglutinine, 5 mg/mL, Abbott, Illinois, USA) were prepared at the same time.
Phenotyping of PBMC was done using the following mAbs: anti-CD4 (74-12-4, IgG2b [17] , anti-IL2R (231-3B2, IgG1, [2] ), R-PE conjugated anti-CD8 (76-2-11, [17] , Pharmingen, CA), anti-IgM (PIG45A, IgG2b, VMRD, Pullmann, WA, USA). Appropriate isotype control labeling was also included in the analysis (Mouse IgG2a, IgG2b and IgG1, Dako, Denmark). The detection of specific proliferating cells was performed in a five-step procedure : 1. Cell labeling with anti-IgM mAb in order to differentiate B and T cells, or anti-CD4 and anti-CD8 to differentiate CD4 and CD8 T-lymphocytes, for 30 min on ice. 2. Incubation with isotype-specific conjugates (goat anti-mouse IgG2a-RPE and goat antimouse IgG2b-TC, CALTAG, Burlingame, CA, USA), again for 30 min on ice. 
CSFV-specific cell activation response
Activation of cells was revealed by the expression of the IL2 receptor (CD25) at the cell surface [2, 23] .
A specific mAb anti-CD25 (anti IL2-R, 231-3B2, IgG1, [2] ) and an appropriate isotype-specific goat anti-mouse IgG1-FITC conjugate (CALTAG, CA, USA) were used. PBMC expressing CD25 were monitored by flow cytometry. Cell phenotyping was also done by triple labeling as described above.
Studies on cytokine profiles
The Th1/Th2-like profile was studied through the quantitative detection of IFNg and IL4 mRNA using the quantitative reverse transcription-polymerase chain reaction (RT-PCR) [8] . Briefly, PBMC were isolated from blood and added to 24-well plates (3´10 6 cells/well). Incubation at 37°C was done for 2 days, in the presence of either phytohemagglutinin (PHA) at 5 mg/mL as a positive control or 100 mL of medium as a negative control or 100 mL of infectious CSF virus (3 ´ 10 7 TCID 50 /mL of cells). Cell mRNA was extracted and IFNg and IL4 mRNA was quantified according to Dufour et al. [8] . The production of IFNg protein by PBMC re-stimulated in vitro was also detected with a commercial interferon kit (Biosource, CA, USA).
Studies of CSF-specific cytotoxic T lymphocytes
PBMC were used directly or after in vitro re-stimulation with infectious CSFV (MOI = 1) for 4 days. The cytotoxic activity was determined against CSFV-infected target cells prepared from pig kidney cells of the d/d haplotype (cell line ddK31 kindly supplied by A. Takamatsu, Pirbright, Surrey, UK). Permanently infected ddK31 cells were obtained after three passages with the Alfort virulent strain. The permanent expression of CSFV antigens was confirmed by labeling with an anti-CSFV monoclonal antibody (PPL 282C10A, kindly provided by Merial, France) and subsequent analysis by flow cytometry. CTL activity was measured by flow cytometry as described by Piriou et al. [18] . Briefly, this assay is based on a dual fluorescent staining of target cells. The dye, DIOC18 (3) (Sigma) was used to stain the membrane of target cells and propidium iodide (PI) to label dead target and effector cells. The cytotoxic activity was analyzed by flow cytometry. Spontaneous death cell (low control, LC) was determined by incubation at 4°C of target and effector cells in order to inhibit effector cell cytotoxic activity. For maximun lysis (high control, HC), target and effector cells were incubated at 37°C with 20 mL of saponin at 0.3 mg/mL. Results are expressed as percentage of cytotoxicity using the following formula: (% of target cell lysis in the test -LC) / (HC -LC).
RESULTS
Preliminary experiments showed that d/d histocompatible pigs were susceptible to CSFV infection by the Alfort strain, as evidenced by hyperthermia, presence of viral RNA, loss of body weight and reduction in leukocyte counts (data not shown). However, under our experimental conditions, this strain was shown to be of moderate virulence since mortality was only seen on exceptional circumstances.
Presence of viral RNA in blood samples after CSFV
RT-PCR was performed for detection of viral RNA in blood samples. Positive samples for virus RNA were observed from days 3 and 7 PI, up to day 28, in the challenged pigs (Tab. I), which indicates a prolonged viraemia. The challenged animals showed only mild clinical signs, a reduction in food intake but no pyrexia. In contrast, no viral RNA was detected in the blood of the "vacc/chall" and control pigs. This absence of virus replication in vaccinated pigs was in accordance with the absence of clinical signs after challenge. Nevertheless, viral RNA in the "chall" pigs and "vacc/chall" pigs was detected at necropsy.
Evolution of blood leukocyte populations after CSFV
Total leukocyte counts decreased on day 7 PI in the challenged pigs, then returned to initial values at 10 days PI and increased on days 13-17 ( Fig. 1) . Leukocyte depletions were not as strong as expected, due to the moderate virulence of the challenge virus strain. In contrast, there was no decrease of the leukocyte counts in the "vacc/chall" and control pigs. No modification of leukocyte counts was observed after immunization. The reduction of leukocyte counts after challenge was time related to the reduction of lymphocyte counts (Fig. 1) . At 7 days PI in challenged pigs, the decrease of total lymphocyte numbers was mainly characterized by a drop of CD4 + CD8 + , CD4 + CD8 -and CD4 -CD8 + cells (Fig. 2) .
Virus-specific lymphocyte activation and proliferation after CSFV
Although CSFV infection induced a decreased number of circulating lymphocytes, these cells were still responsive to in vitro antigen stimulation. Lymphocyte activation, as measured in FCM by the expression of membrane IL2-R (CD25), was only detected in challenged pigs, from 10 to 60 days PI (Fig. 3) . No lymphocyte activation was detectable in the "vacc/chall" pigs, 3 weeks after vaccination (i.e. day 0 PI), or after challenge, nor in the control animals. CSFV-driven activation of cells in challenged animals was detected in the CD4 -CD8 + cell subset, with the highest response between 15 and 25 days PI (Fig. 3) . A much lower activation was also observed in the CD4 + CD8 + cell subset between 35 and 68 days PI. As
Post immunization days (PID)
Post challenge days (PCD) Figure 1 . Kinetics of blood leukocytes and lymphocytes counts in uninfected control pigs (u), challenged pigs (n) and vaccinated/challenged pigs (p) after CSFV immunization and challenge (PID 21). Each color (black and grey) represents one animal.
expected, we could not detect antigendriven activation of CD4 + CD8 -cells because it is known that this subset acquires CD8 upon activation [22] . CSFV-specific lymphocyte proliferation was also assessed by BRDU incorporation. A positive proliferative response was only observed in one of the two challenged pigs. In this pig, a high proliferative response was detected in T and B cell subpopulations, between 25 and 60 days PI. This in vitro proliferation was observed in CD4 + CD8 -and CD4 -CD8 + cells (Fig. 4) . No CSFV-specific lymphocyte proliferation was detected in the "vacc/chall" pigs 3 weeks after vaccination (day 0 PI), or after challenge, nor in control animals. The comparison of BRDU incorporation with CD25 expression showed differences with respect to the kinetic and responding populations. This could be because activation as evidenced by CD25 expression does not necessarily lead to a detectable proliferation, and because not all proliferating cells do express CD25.
Specific CTL activity after CSFV
Cytotoxic T lymphocytes (CTL) were evaluated by flow cytometry using either non-restimulated PBMC or PBMC restimulated in vitro by the virulent Alfort strain for 4 days. Target cells were CSFV infected d/d kidney cells. Controls were also done to assess the non-specific cytolytic activity against non infected target cells. Results in Figure 5a-1 show that nonspecific activity was not observed when PBMC were not re-stimulated in vitro. However, a positive specific primary CTL activity was observed with PBMC collected from one of challenged pigs, at (Fig. 5a-2) . No primary specific CTL activity was observed in control or vaccinated and challenged animals, at any time after vaccination or challenge. After in vitro re-stimulation with CSFV, a weak non-specific cytotoxicity was observed against uninfected target cells at 40 days PI in the "vacc/chall" and "chall" pigs ( Fig. 5b-3 ). However, a high specific secondary cytotoxic activity was detected in PBMC of challenged pigs by 20 days PI (up to 65% of cytotoxicity) (Fig. 5b-4) . This activity persisted at high levels up to 68 days PI. In contrast, specific secondary cytotoxic activity in the "vacc/chall" pigs was absent 3 weeks after vaccination (day 0 PI), low after challenge. No CTL activity was detected in control animals. At the end of the experiment (74 days PI), the level of the specific CTL activity of challenged animals returned to baseline values (Fig. 5). 
Kinetics of CSFV-induced cytokine expression after infection
After in vitro re-stimulation of PBMC with infectious virus for 2 days, cell culture supernatants were evaluated for the secretion of IFNg by ELISA and the cells were treated for the detection of IFNg and IL4 mRNA by quantitative RT-PCR. IFNg mRNA copies were detected in "vacc/ chall" and "chall" pigs (Fig. 6a) . The number of IFNg mRNA copies was higher in "chall" pigs compared to "vacc/chall" pigs from day 21 PI onwards. In "vacc/ chall" pigs, IFNg mRNA was detected early after infection, at 7 days PI, suggesting an anamnestic response due to vaccination of those pigs, but no IFNg mRNA was detected 3 weeks after vaccination (day 0 PI). The detection of mRNA IFNg was correlated with the production of IFNg in cell supernatants (Fig. 6a) . In contrast to IFNg , IL4 mRNA copies were detected only at low levels in all pigs.
Antibody responses to CSFV
CSFV neutralizing serum antibodies were detected 21 days PI in the challenged animals, and 10 days after vaccination in the "vacc/chall" pigs (Tab. I). Although a secondary Ab production was observed after challenge in the "vacc/chall" pigs, a much higher level of Ab was reached Post inoculation days (PID) Post challenge days (PCD) in the non vaccinated challenged animals (Tab. I). Three weeks after vaccination in the "vacc/chall" pigs (day 0 PI), a low anti-CSFV IgG response was detected which increased after challenge, again suggesting an anamnestic response (Fig. 7) . In the challenged pigs, higher CSF-specific IgG, IgG1 and IgA responses were observed from day 21 PI, as compared to the "vacc/ chall" pigs. 
DISCUSSION
The objective of this study was to analyze in details the kinetics of cell-mediated immune responses to CSFV, including antigen-driven activation and proliferation of lymphocyte subsets, primary and secondary specific CTL activity and cytokine responses. In order to conduct CTL assays, histocompatible d/d pigs were used. To perform a prolonged kinetic study of immune responses after infection, early death of the animals after CSFV challenge had to be avoided. We therefore decided to infect pigs by the oronasal route with a low dose of virus (10 4.5 TCID 50 of the virulent Alfort strain). In these pigs, we observed only mild clinical signs: a reduction in food intake, no pyrexia, along with a drop in blood leukocyte counts 7 days PI. Although the challenge was moderate, viral RNA was detected in blood from 3-7 days PI up to 28 days PI in the "chall" pigs. On the other hand, we also used in two other pigs, a IM vaccination three weeks after challenge with the Alfort strain to induce a strong immune response against CSFV. In contrast with the previous pigs, those pigs were protected against the challenge, as shown by the absence of any clinical signs, virus replication and drop of leukocyte counts. The blood leukocyte depletion after infection of non vaccinated animals corresponded to a specific reduction of CD4 + and/or CD8 + T cells. These results were in accordance with the reports of Summerfield et al. [25] and Lee et al. [10] who described a depletion of CD4 T cells during acute CSF, and with the data from Markowska-Daniel et al. [12] showing a strong depletion of CD8 + . However, this observation contrasted with the results of Susa et al. [28] where the B cell subset was more affected than the T cell subsets.
The end-point for viral RNA detection coincided with the presence of high titers of serum neutralizing antibodies. However, titers were always lower in the "vacc/chall" pigs compared to the "chall" pigs. This could be due to the reduction of virus replication in the vaccinated pigs, leading to a reduced immune stimulation after challenge. The same difference was seen on IgG (IgG1) and IgA by ELISA. The challenge by the oronasal route without prior immunization gave substantial amounts of circulating CSFV-specific IgA. IgG1 and IgG2 antibody responses were differentially modulated in the two groups of animals, which may reflect different "Th1/Th2" like modulations depending upon immunization protocols. While infected pigs developped a strong IgG1 and IgG2 response, the "vacc/chall" animals only displayed IgG2 responses. Together with the high IFN-g and cytotoxic responses, this would indicate that infection of pigs is more associated with the Th1 responses compared to the "vacc/chall" protocol. However, the concept of "Th1/Th2" balance is not yet well documented in pigs.
A major focus was made on kinetics of cell-mediated immune responses: CSFVspecific activation of CD4 -CD8 + T cells was observed early post-infection in the "chall" pigs. In addition, CD4 + CD8 + T-cells, considered as memory T cells [26, 35] were also activated later on. Interestingly, we could not detect activation of CD4 + CD8 -cells. Surprisingly, only one of the "chall" pigs showed a high CSFV-specific proliferation response. With this pig, an early activation of CD4 -CD8 + cells and a high specific CTL response was induced. Surprisingly, in this pig, the CSFV-specific proliferative response was also observed in IgM + B cells. Among T cell subsets, both CD4 + T cells and CD8 + T cells were induced to proliferate after re-stimulation with the virulent CSFV strain. Our results are divergent from those of Kimman et al. [9] who showed that mainly CD8 + cells proliferate while CD4 + do not. The difference may be due to the methods or the protocols used. We used a direct labeling of proliferating cells while Kimman et al. [9] depleted different cell subsets before detection of proliferation by tritiated thymidine incorporation. Compared to challenged animals, vaccination did not induce detectable activation of lymphocytes within 3 weeks after vaccination, nor after challenge.
Primary CSFV-specific CTLs, i.e. without any in vitro re-stimulation by the virus, were found in PBMC of one "chall" pig. These circulating CTLs, were highly active at 3 weeks PI and then persisted up to 74 days PI. They may play a role in vivo for clearing virus-infected cells and thus enabling the infected pigs to control CSFV replication by days 21 to 28 post-infection as shown by the results of RNA detection, and finally to escape the development of a chronic infection. Such a high and prolonged level of primary CTL activity was constrasting with the report of Pauly et al. [15] in which repeated infections of pigs and in vitro re-stimulation were necessary for generating virus-specific CTLs. In our study, the in vitro re-stimulation increased the CTL activity in the two "chall" pigs but not in the others. This might relate to the route of vaccination or challenge which was different. Interestingly, this CTL activity was concomitant with the production of IFNg in re-stimulated T cells. A recent publication of Suradhat et al. [27] showed the high IFNg production following CSFV infection. This IFNg production may contribute to the generation of CTL as observed in our study. We provide here a clear connection between the two responses thus showing that the detection of IFNg may be a good indicator of CTL response in pigs.
In conclusion, we show that a single infection with the Alfort virulent strain by the oronasal route was able to induce important CSFV-specific cell-mediated immune responses in d/d histocompatible pigs: activation and proliferation of CD4 + CD8 + , CD4 + CD8 -and CD4 -CD8 + cells, production of IFNg and generation of CTL. These responses were absent after intramuscular vaccination with an attenuated virus and considerably lower after challenge of vaccinated pigs. Thus, although this vaccination could protect animals to challenge and induce antibodies, it did not induce detectable T-cell responses. It also became clear from this study that the influence of intramuscular compared to intranasal vaccination or challenge requires further consideration. In a preliminary study of passive transfer of protection to CSFV in d/d pigs, donor CD2 + cells from vaccinated pigs were indeed unable to protect recipient pigs from virus challenge, whereas the immune serum, as expected, did it [19] . Therefore, our findings of high cell-mediated and humoral responses after infection by the oronasal route reinforce the need to develop new strategies for vaccine improvement, specifically in view of the development of high cell mediated responses in the context of deleted or marker vaccines. Such vaccines are awaited for use under emergency conditions, to allow rapid discrimination between infected and vaccinated pigs [6, 31] . Subunit vaccines were recently developed for that purpose [4] but proved to be of moderate efficacy under emergency [7, 30] . The methods that we developed in our study will help future identifications of new CSFV antigens as powerful targets for CTL and T-cell responses, likely prerequisites for the rationale development of improved marker vaccines.
